Meeting Banner
Abstract #1895

Perfusion decrease during radiochemotherapy is not fully explained by volumetric gray matter changes

Jan Petr1, Henri JMM Mutsaerts2,3, Frank Hofheinz1, Iris Asllani4, Matthias JP van Osch5, Ivan Platzek6, Annekatrin Seidlitz7,8,9,10, Mechthild Krause7,8,9,10,11, and Jörg van den Hoff1,12

1PET center, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany, 2Brain Sciences Research Program, Sunnybrook Research Institute, Toronto, Canada, 3Department of Radiology, Academic Medical Center, Amsterdam, Netherlands, 4Rochester Institute of Technology, Rochester, NY, United States, 5Department of Radiology, Leiden University Medical Center, Leiden, Netherlands, 6Department of Radiology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany, 7Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany, 8OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Dresden, Germany, 9German Cancer Consortium (DKTK), Dresden, Germany, 10German Cancer Research Center (DKFZ), Heidelberg, Germany, 11Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany, 12Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

Radiochemotherapy in brain-tumor patients was shown to cause gray matter (GM) volume and cerebral blood flow (CBF) changes. The interaction of these two effects, however, remains unclear. Here, we investigated GM volume and ASL CBF changes and their interaction in the healthy hemisphere of 38 glioblastoma patients undergoing radiochemotherapy with Temozolomide. We found a statistically significant CBF decrease with dependence on the RT-dose. PV-corrected results indicated that, while to a certain extent the apparent CBF decrease measured by ASL is caused by GM atrophy, there still remain significant CBF changes that cannot be explained by structural changes alone.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords